5901 - 5950 of 9148 Results
Title
Year
- Hoehn and Yahr stage 3 and postural stability item in the movement disorder society–unified Parkinson's disease rating scale2018RESTRICTEDTitle: Hoehn and Yahr stage 3 and postural stability item in the movement disorder society–unified Parkinson's disease rating scaleJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 7Start Page: 1188End Page: 1189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27453Citation Count: 7
- Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard2019RESTRICTEDTitle: Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide StandardJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 18Issue #: 6Start Page: 2422End Page: 2432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00920Citation Count: 17
-
OPENTitle: CSF alpha‐synuclein aggregates by seed amplification and clinical presentation of ADJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 8Start Page: 3754End Page: 3759Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13109Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13109Citation Count: 39
-
OPENTitle: Structure-based optimization and binding assays for discovery of tau PET radiotracers: synthesis and in vivo evaluation of [ 11 C]Z-3272Journal Name: Canadian Journal of ChemistryPublisher: Canadian Science PublishingVol: 104Issue #: 4Start Page: 349End Page: 355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1139/cjc-2025-0058Best OA location URL: https://doi.org/10.1139/cjc-2025-0058Citation Count: 0
- PTPA variants are rare in early-onset and familial Parkinson’s disease2023RESTRICTEDTitle: PTPA variants are rare in early-onset and familial Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: e125End Page: e127Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awad244Citation Count: 2
- Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progression2021RESTRICTEDTitle: Impact of the apolipoprotein E ε4 allele on early Parkinson's disease progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 66End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.004Citation Count: 16
-
OPENTitle: Reduced serum interleukin-2 associates with higher motor severity and along with CD4 T cell alterations may be an early event in isolated REM Sleep Behaviour DisorderJournal Name: Brain, Behavior, & Immunity - HealthPublisher: Elsevier BVVol: 54Issue #:Start Page: 101257End Page: 101257Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbih.2026.101257Best OA location URL: https://doi.org/10.1016/j.bbih.2026.101257Citation Count: 0
-
OPENTitle: Keep calm and beam on? Unmet needs in radiotherapy and deep brain stimulationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 71Issue #:Start Page: 15End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.01.005Best OA location URL: http://www.prd-journal.com/article/S1353802020300055/pdfCitation Count: 2
-
OPENTitle: Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individualsJournal Name: European Journal of NeurologyPublisher: WileyVol: 30Issue #: 5Start Page: 1281End Page: 1292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.15733Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15733Citation Count: 9
- A late-onset neurological disorder: is progression inevitable?2022RESTRICTEDTitle: A late-onset neurological disorder: is progression inevitable?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105092End Page: 105092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014Citation Count: 0
- Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort study2019RESTRICTEDTitle: Anemia in men and increased Parkinson's disease risk: A population-based large scale cohort studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 64Issue #:Start Page: 90End Page: 96Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.010Citation Count: 17
-
OPENTitle: Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomalironimagingin Parkinson’s disease)Journal Name: BMJ OpenPublisher: BMJVol: 7Issue #: 12Start Page: e016904End Page: e016904Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2017-016904Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/7/12/e016904.full.pdfCitation Count: 8
-
OPENTitle: Recruitment strategies in a diverse Parkinson’s disease cohort: lessons from the East London Parkinson’s Disease ProjectJournal Name: BMJ Neurology OpenPublisher: BMJVol: 8Issue #: 2Start Page: e001732End Page: e001732Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjno-2026-001732Best OA location URL: https://neurologyopen.bmj.com/content/8/2/e001732.full.pdfCitation Count: 0
-
OPENTitle: The pattern of fMRI activation with STN DBS reveals symptom-specific networksJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-026-01368-xBest OA location URL: https://www.nature.com/articles/s41531-026-01368-x_reference.pdfCitation Count: 0
-
OPENTitle: α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cellsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 2Start Page: 715End Page: 725Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43366Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gs-1/7841Citation Count: 838
-
OPENTitle: Clinical implications of early caudate dysfunction in Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 10Start Page: 1098End Page: 1104Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2018-320157Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/10/1098.full.pdfCitation Count: 94
-
RESTRICTEDTitle: Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies – a mini reviewJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 32Issue #: 4Start Page: 23End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s10286-022-00882-1Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10101699/pdf/nihms-1885470.pdfCitation Count: 0
-
OPENTitle: Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot StudyJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 851End Page: 863Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212833Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9181238Citation Count: 6
-
OPENTitle: Targeting specific kinase substrates rescues increased colitis severity induced by the Crohn’s disease–linked LRRK2-N2081D variantJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 135Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci190017Best OA location URL: https://doi.org/10.1172/jci190017Citation Count: 2
-
OPENTitle: The Effects of Deep Brain Stimulation in Patients with Multiple System AtrophyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 8Start Page: 2595End Page: 2600Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-223504Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10077954/pdf/nihms-1879945.pdfCitation Count: 14
- The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy2021OPENTitle: The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System AtrophyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 105End Page: 115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212877Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212877?id=journal-of-parkinsons-disease%2Fjpd212877Citation Count: 19
-
OPENTitle: APOE,MAPT, andSNCAGenes and Cognitive Performance in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 11Start Page: 1405End Page: 1405Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.1455Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/1900308/noi140049.pdfCitation Count: 210
-
OPENTitle: Striatal Pleiotrophin Overexpression Provides Functional and Morphological Neuroprotection in the 6-Hydroxydopamine ModelJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 20Issue #: 3Start Page: 544End Page: 554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.216Best OA location URL: http://www.cell.com/article/S1525001616305111/pdfCitation Count: 32
-
OPENTitle: Long-term Transgene Expression in the Central Nervous System Using DNA NanoparticlesJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 641End Page: 650Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.2Best OA location URL: http://www.cell.com/article/S152500161631557X/pdfCitation Count: 80
- Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects2014RESTRICTEDTitle: Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction EffectsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 2Start Page: 194End Page: 194Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2757Citation Count: 166
-
OPENTitle: The natural history of multiple system atrophy: a prospective European cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 12Issue #: 3Start Page: 264End Page: 274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(12)70327-7Best OA location URL: http://www.thelancet.com/article/S1474442212703277/pdfCitation Count: 535
-
OPENTitle: Highlights of the Stockholm Congress: A Clinician's PerspectiveJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 277End Page: 279Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12093Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12093Citation Count: 0
-
OPENTitle: Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 VectorsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 1490End Page: 1495Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2010.114Best OA location URL: http://www.cell.com/article/S1525001616310991/pdfCitation Count: 83
-
OPENTitle: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 7Issue #: 7Start Page: 583End Page: 590Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(08)70117-0Best OA location URL: http://www.thelancet.com/article/S1474442208701170/pdfCitation Count: 1565
-
OPENTitle: Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 1048End Page: 1057Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2011.11Best OA location URL: http://www.cell.com/article/S1525001616319098/pdfCitation Count: 144
-
OPENTitle: Comparative Transduction Efficiency of AAV Vector Serotypes 1–6 in the Substantia Nigra and Striatum of the Primate BrainJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 18Issue #: 3Start Page: 588End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2009.286Best OA location URL: http://www.cell.com/article/S1525001616323085/pdfCitation Count: 130
-
OPENTitle: Neuronal gene expression correlates of Parkinson's disease with dementiaJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 11Start Page: 1588End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22184Best OA location URL: http://doi.org/10.1002/mds.22184Citation Count: 51
-
OPENTitle: Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson’s DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 2169End Page: 2180Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2013.169Best OA location URL: http://www.cell.com/article/S1525001616309431/pdfCitation Count: 61
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 43
- Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease2010RESTRICTEDTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Citation Count: 1
-
OPENTitle: Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12104Citation Count: 5
-
OPENTitle: Incidental Lewy body disease: Clinical comparison to a control cohortJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 5Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22971Best OA location URL: http://doi.org/10.1002/mds.22971Citation Count: 141
- The relationship between uric acid levels and Huntington's disease progression2010RESTRICTEDTitle: The relationship between uric acid levels and Huntington's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 2Start Page: 224End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22907Citation Count: 91
-
OPENTitle: Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 1572End Page: 1579Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2008.146Best OA location URL: http://www.cell.com/article/S1525001616320548/pdfCitation Count: 117
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3140626Citation Count: 8
-
OPENTitle: Brain biochemistry in autopsied patients with essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 1Start Page: 113End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3261329Citation Count: 54
-
OPENTitle: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1966End Page: 1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25647Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859844Citation Count: 143
- Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease2011RESTRICTEDTitle: Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 11Start Page: 2051End Page: 2057Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23792Citation Count: 85
-
OPENTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7041965Citation Count: 1110
-
OPENTitle: Caffeine consumption and risk of dyskinesia in CALM‐PDJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 380End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3608707Citation Count: 58
- Caffeine and risk of Parkinson's disease in a large cohort of men and women2012RESTRICTEDTitle: Caffeine and risk of Parkinson's disease in a large cohort of men and womenJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 10Start Page: 1276End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25076Citation Count: 189
-
OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: http://doi.org/10.1002/mds.25637Citation Count: 9
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4050667Citation Count: 11
-
RESTRICTEDTitle: Disease‐related and genetic correlates of psychotic symptoms in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2190End Page: 2195Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23806Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4216677Citation Count: 68
-
OPENTitle: Hedonic and behavioral deficits associated with apathy in Parkinson's disease: Potential treatment implicationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 9Start Page: 1301End Page: 1304Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25496Best OA location URL: http://doi.org/10.1002/mds.25496Citation Count: 38